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Abstract
Background: The American College of Obstetricians and Gynecologists (ACOG) introduced a new standard of care
in 2014, extending the duration of the second stage of labor in order to reduce caesarean delivery (CD) rates and
its severe complications. The aim of the present study is to evaluate success rates of trial of labor after caesarean
section (TOLAC), as well as maternal and neonatal outcomes after the establishment of the recent guidelines.
Methods: A retrospective study was performed at two large departments in Germany from January 2008 to
January 2018. Patients undergoing TOLAC were divided into two groups. Group I (958 patients) was constituted
before the establishment of the current guidelines, and Group II (588 patients) after the establishment of the
guidelines. A subgroup analysis was performed to compare neonatal outcomes after successful TOLAC and
operative vaginal delivery with those after failed TOLAC and secondary CD.
Results: The success rate of vaginal births after cesarean section (VBAC) fell from 66.4% in Group I to 55.8% in Group II
(p < 0.001). The median duration of the second stage of labor was statistically significantly longer in Group II than in
Group I (79.3 ± 61.9 vs. 69.3 ± 58.2 min) for patients without previous vaginal birth. The incidence of operative vaginal
delivery decreased from Group I to Group II (9.6% vs. 6.8%). The incidence of third- and fourth-degree perineal
lacerations, blood loss and emergency CD were similar in the two groups. Concerning the neonatal outcome, our
groups did not differ significantly in regard of rates of umbilical artery cord pH < 7.1 (p = 0.108), the 5-min Apgar scores
below 7 (p = 0.224) and intubation (p = 0.547). However, the transfer rates to the neonatal care unit were significantly
higher in Group II than in Group I (p < 0.001). Neonatal outcomes did not differ significantly in the subgroup analysis.
Conclusion: Extending the second stage of labor does not necessarily result in more vaginal births after TOLAC.
Maternal and neonatal outcomes were similar in both groups. Further studies will be needed to evaluate the role of
operative vaginal delivery and the duration of the second stage of labor in TOLAC.
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Background
There has been a notable increase in the number of
caesarean deliveries (CD) over the last decade through-
out the world. In the United States, CD rates rose from
5% of all deliveries in 1970 to 31.9% in 2016 [1]. In some
countries, a CD is considered necessary or is offered to
women who have had previous caesarean sections. This
has contributed to the overall increase in CD rates [2].
Thus, the trial of labor after caesarean section (TOLAC)
is an essential strategy to reduce CD rates. Vaginal birth
after caesarean section (VBAC) is achieved in 65 to
83.3% of cases [3, 4]. Although VBAC is a safe medical
procedure, VBAC rates have declined throughout the
world in the last few years. Conversely, the rate of
elective repeat caesarean section (ERCS) is on the rise
[5]. In the United States, the overall rate of VBAC fell
from 24% in 1996 to 8% in 2010, which is a matter of
public and professional concern [6]. One reason for this
phenomenon may be ambiguous evidence of the risks of
VBAC, which causes fear and anxiety in patients [7].
In general, CD is associated with more severe maternal
complications [8] compared to vaginal deliveries. The
benefits of vaginal birth, such as rapid maternal recov-
ery, fewer maternal complications in future pregnancies,
and a potentially lower risk of childhood diseases (such
as allergies, asthma, or obesity) should be taken into
account [9]. A number of studies published in recent
times have addressed the outcome of TOLAC and
yielded variable results. However, VBAC is overall rela-
tively safe for mother and child compared to ERCS [10].
Successful VBACs have been associated with lower overall
morbidity rates [11] compared to ERCS. However, a failed
VBAC is associated with a higher risk of perinatal and
maternal complications compared to ERCS [12].
Based on guidelines published by the ACOG (American
College of Obstetricians and Gynecologists) and SMFM
(Society for Maternal Fetal Medicine) in 2014 [13], many
hospitals throughout the world have introduced a new
standard of care concerning the duration of the second
stage of labor in order to reduce CD rates. According to
these recommendations, the second stage of labor may
take an indefinite period of time, provided the delivery
progresses well, and maternal and fetal wellbeing are
ensured. This statement has been endorsed by other rec-
ommendations [14, 15] and studies [16]. In contrast, the
previous guidelines [17, 18] recommended a maximum
duration of approximately 1 or 2 h in multiparous women
for the second stage of labor, depending on whether or
not a regional anesthesia was performed. The correlation
between the duration of the second stage of labor and
adverse maternal and neonatal outcomes has been investi-
gated in several studies [19, 20].
The purpose of the present study is to investigate the
consequences of the most recent ACOG/SMFM guidelines
with respect to success rates of TOLAC. We also analyzed
maternal and fetal outcomes.
Material and methods
A retrospective multicenter study was performed at two
large departments of obstetrics and gynecology in
Germany, including patients with high-risk pregnancies,
from January 2008 to January 2018. The study was
performed in compliance with the Helsinki declaration,
and was approved by the medical ethics committee. The
hospital information systems of the academic teaching
hospitals of Klinikum Leverkusen and the University
Hospital of Luebeck in Germany were used to identify
eligible patients. Inclusion criteria were defined as
singleton pregnancy, a history of only one previous
caesarean delivery with a low transverse incision, a viable
fetus in cephalic presentation, patients > 32 weeks of
gestation [a vaginal delivery under this gestational age
was not favored earlier at the above mentioned our
institutions [21–23]], and the intention to deliver by the
vaginal route.
A computer-based search yielded 4139 patients with
only one previous caesarean section in their medical
history. Approximately a half of them had undergone an
elective repeat caesarean section. Further exclusion
criteria were emergencies before labor, intrauterine
growth restriction, fetal anomalies, and multiple gesta-
tion. Finally, 1546 patients (607 from Leverkusen and
939 from Luebeck) fulfilled the inclusion criteria (Fig. 1).
Parity, clinical parameters such as age, body mass
index (BMI), gestational age, preterm birth, the
occurrence of a vaginal birth or VBAC before TOLAC,
gestational diabetes, and hypertensive pregnancy-related
diseases were analyzed. Maternal surveillance data such
as birth analgesia, labor induction, maternal outcomes
(estimated blood loss, emergency CD, uterine rupture,
third- and fourth-degree perineal tears, episiotomy,
postoperative hysterectomies), and fetal outcomes (fetal
weight, umbilical artery cord pH < 7.1 or < 7.0, 5-min
Apgar scores below 6 or 7, intubation rate, and transfer
to neonatal care unit) were analyzed. Oxytocin or
prostaglandin were used for the induction of labour. The
exact duration of the second stage of labor was
registered. Both departments adopted the guidelines
published by the ACOG in 2014 concerning the
duration of second stage of labor and were universally
carried out, Furthermore, the same standards of care
were maintained at both institutions. A subgroup
analysis was performed to compare neonatal outcomes
after VBAC with vaginal operative delivery and failed
TOLAC with secondary CD.
The patients were divided into two groups in order to
compare VBAC, maternal and fetal outcomes after
TOLAC in relation to the duration of the second stage
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of labor. Group I (958 patients) included deliveries from
January 2008 to March 2014 at the University Hospital
of Luebeck, and from January 2008 to March 2014 at
the academic teaching hospitals of Klinikum Leverkusen
(time period I). Deliveries from April 2014 to January
2018 (time period II), constituted Group II (588
patients). The second stage of labor was defined as the
period of time from complete dilatation of the cervix to
the delivery of the infant. During time period I, a
second-stage arrest was established when the second
stage persisted for 2 or 3 h, required regional anesthesia
in nulliparous women, and a caesarean section had to be
considered. In multiparous women, a second-stage arrest
was established after 1 or 2 h, coupled with a need for
regional anesthesia [17, 18]. In Group II, based on new
standards published in 2012 [15] and 2014 [13], no abso-
lute maximum length of time was defined for the second
stage of labor; at least one additional hour elapsed before
a second-stage arrest was established. A subgroup
analysis was performed to compare neonatal outcomes
after VBAC with operative vaginal delivery and failed
TOLAC with secondary CD.
Statistical analysis was performed using the SPSS
software. Continuous and categorical variables were
shown as numbers of patients and percentages. Depend-
ing on the scaling and distribution of the variables
considered, either a chi-square-test or a Fisher’s exact
test was performed. P-values less than or equal to 0.05
were considered statistically significant.
Results
Baseline characteristics and maternal surveillance were
similar in both groups (958 women in Group I and 588
women in Group II) (Table 1). The median duration of
the second stage of labor was longer in Group II (65.4 ±
60.7 min) than in Group I (57.4 ± 56.3 min), but the
difference was not statistically significant (p = 0.098).
However, the median duration of the second stage of
labor was significantly longer in patients without previous
vaginal delivery (79.3 ± 61.9min in Group II vs. 69.3 ±
58.2min in Group I) (p = 0.045).
As shown in Table 2, the rate of successful TOLAC
fell from 66.4% (636/958 patients) in Group I to 55.6%
(327/588) in Group II (p < 0.001), while CD rates increased
Fig. 1 Flowchart through the recruitment phase of the study
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Table 1 Patient characteristics
Group I (n = 958) Group II (n = 588) Total (n = 1564) p
Age (years) 32.5 ± 5.1 32.5 ± 4.9 32.5 ± 5.0 0.702
Parity 2.4 ± 0.8 2.3 ± 0.8 2.4 ± 0.80 0.055
Gestational age (weeks) 39.0 ± 2.1 39.0 ± 2.1 39.1 ± 2.1 0.182
BMI (kg/m2) 25.4 ± 5.6 26.0 ± 6.2 25.7 ± 5.8 0.197
Previous vaginal birth 211 (28.7%) 136 (23.6%) 347 (26.4%) 0.036
Prostaglandin used 264 (27.6%) 213 (36.2%) 477 (30.9%) < 0.001
Oxytocin used 410 (42.9%) 160 (27.2%) 570 (36.9%) < 0.001
Oxytocin and prostaglandin used 117 (12.2%) 61 (10.4%) 178 (11.5%) 0.271
Gestational diabetes 110 (11.5%) 61 (10.4%) 171 (11.1%) 0.503
Hypertensive, pregnancy-related disease 51 (5.3%) 34 (5.8%) 85 (5.5%) 0.699
Birthweight of previous infant delivered by CD (g) 3049 ± 811 3059 ± 816 3052 ± 811 0.649
Neonatal weight (g) 3351 ± 587 3332 ± 586 3344 ± 586 0.757
Preterm birth (≤ 36 + 6 weeks of gestation) 114 (11.9%) 72 (12.2%) 186 (12.0%) 0.840
Median duration of the second stage of labor (minutes) (n = 789) 57.4 ± 56.3 65.4 ± 60.7 61.0 ± 58.5 0.098
Median duration of the second stage of labor (minutes) for patients
with previous vaginal birth (n = 227)
28.3 ± 38.3 31.82 ± 42.3 29.91 ± 40.1 0.910
Median duration of the second stage of labor (minutes) for patients
without previous vaginal birth (n = 560)
69.3 ± 58.2 79.3 ± 61.9 73.8 ± 60.0 0.045
Table 2 Maternal and neonatal outcome
Group I (n = 958) Group II (n = 588) Total (n = 1564) p
Successful TOLAC = VBAC 636 (66.4%) 327 (55.6%) 963 (62.3%) < 0.001
Vaginal operative delivery 92 (9.6%) 40 (6.8%) 132 (8.5%) 0.003
Secondary cesarean section 323 (33.7%) 257 (43.7%) 580 (37.5%) < 0.001
Episiotomy 215 (22.4%) 79 (13.4%) 294 (19.0%) < 0.001
Third- or fourth degree of perineal laceration 9 (0.9%) 7 (1.2%) 16 (1.0%) 0.636
Blood loss (ml) 333 ± 388 331 ± 204 332 ± 319 0.095
Emergency CD 10 (1.9%) 11 (2.6%) 21 (2.2%) 0.449
Uterine rupture 10 (1.0%) 10 (1.7%) 20 (1.3%) 0.267
Apgar score at 1 min (mean) 8.46 ± 1.28 8.50 ± 1.42 8.48 ± 1.33 0.017
Apgar score at 5 min (mean) 9.50 ± 0.97 9.55 ± 1.05 9.52 ± 1.00 0.011
Apgar score at 10 min (mean) 9.78 ± 0.77 9.73 ± 0.95 9.75 ± 0.85 0.854
Umbilical cord pH 7.30 ± 0.09 7.28 ± 0.09 7.29 ± 0.09 < 0.001
Base excess −3.05 ± 3.32 −3.04 ± 3.51 −3.04 ± 3.41 0.714
Transfer to neonatal care unit 19 (4.4%) 20 (11.7%) 39 ± 6.5% < 0.001
Intubation 7 (1.2%) 8 (1.7%) 15 ± 1.4% 0.547
5-min Apgar score below 6 8 (0.8%) 7 (1.2%) 15 (1.0%) 0.489
5-min Apgar score below 7 12 (1.3%) 12 (2.0%) 24 (1.6%) 0.224
pH < 7.1 10 (1.0%) 12 (2.0%) 22 (1.4%) 0.108
pH < 7.0 3 (0.3%) 5 (0.9%) 8 (0.5%) 0.166
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from 33.7 to 43.7% (p < 0.001). Vacuum-assisted deliveries
accounted for 13.7% of vaginal, and 8.5% of total deliveries.
The incidence of operative vaginal deliveries fell from
Group I to Group II (92 to 40 patients in total; 9.2% vs.
6.8%; p = 0.03).
With regard to maternal outcome (Table 2), no differ-
ences were registered in respect of emergency CD’s,
uterine rupture, third- and fourth-degree perineal and
severe vaginal lacerations, and blood loss by extending
the second stage of labor. Two postpartum hysterecto-
mies were performed (one in each group).
With regard to neonatal outcomes, the umbilical ar-
tery cord pH < 7.1 and the 5-min Apgar scores below 6
or 7 did not have a statistically significant difference
between the two groups. Furthermore, they presented
similar Apgar scores at 10 min (p = 0.854) and intubation
rates (p = 0.547). On the other hand, transfer rates to the
neonatal care unit were significantly higher in Group II
than in Group I (p < 0.001) (Table 2).
A subgroup analysis of neonatal outcomes after vaginal
operative delivery compared with secondary CD is
shown in Table 3. The 5-min Apgar scores below 6 or 7
did not differ statistical significantly between the two
groups. Moreover, intubation rates (p = 0.705), rates of
transfer to the neonatal care unit (p = 0.371), and the
frequency of an umbilical cord pH < 7.1 (p = 0.731) were
similar in both groups.
Discussion
To our knowledge, this is the first study addressing the
outcome of TOLAC with reference to the ACOG/
SMFM recommendations [13]. A low CD rate is one of
the prime objectives of obstetricians throughout the
world [15]. Our data showed that adherence to the
guidelines were associated with a significantly longer
duration of the second stage of labor in patients without
previous vaginal delivery, an unexpected fall in VBAC
rates, and a rise in secondary CD rates after TOLAC.
Moreover, the extension of the second stage of labor
was associated with a significant fall in operative vaginal
deliveries. Maternal and neonatal outcomes did not
differ significantly between groups. Both groups were
homogenous in regard of clinical parameters and out-
come factors.
A few studies have addressed the effectiveness of the
new labor guidelines to prevent primary CD in all
women. The results were controversial. A study from
Pennsylvania, USA, revealed a fall in CD rates from 26.9
to 18.8% in nulliparous patients after the new labor
guidelines [24]. Zipori et al. included multiparous and
nulliparous women in their analysis, and registered a de-
crease in CD rates from 23.3 to 15.7% [25]. By contrast,
a study comprising 7845 patients [26] indicated that CD
rates were not reduced after application of the new labor
guidelines (15.8% vs. 17.7%). The management of the
second stage of labor with the aim of preventing primary
CD is apparently still a debated issue.
Our results were similar to the observational data
obtained from the OptiBIRTH randomized trial [27]:
790 patients undergoing TOLAC from Ireland, Italy, and
Germany were analyzed. Patients with a shorter duration
of labor had more successful VBAC compared to those
with a longer duration of labor. The first and second
stage of labor in the OptiBIRTH trial was 4.68 vs. 7.83 h
(p < 0.001), and 0.70 vs. 2.13 h (p < 0.001), respectively.
Moreover, an earlier intrapartum intervention, such as
amniotomy, was significantly associated with more
VBAC (3.50 h vs. 6.08 h). The authors conclude that a
shorter duration of labor favors VBAC, and the progres-
sion of labor may be assisted by stimulating endogenous
uterine contractions. The effectiveness of stimulating
endogenous uterine contractions could not be evaluated
in the present study because of its retrospective design.
We observed a decrease in the total number of opera-
tive vaginal deliveries after the application of the new
guidelines. This might have been due to the different
Table 3 Neonatal outcome of vaginal operative delivery (VOD) in comparison with secondary caesarean section
VOD (n = 135) Secondary CD (n = 577) Total (n = 712) p
Apgar at 1 min (mean) 7.87 ± 1.59 8.13 ± 1.68 8.08 ± 1.66 0.002
Apgar at 5 min (mean) 9.27 ± 1.01 9.24 ± 1.20 9.25 ± 1.16 0.904
Apgar at 10 min (mean) 9.65 ± 0.67 9.60 ± 0.91 9.60 ± 0.88 0.805
pH 7.23 ± 0.10 7.31 ± 0.10 7.29 ± 0.10 < 0.001
pH < 7.1 3 (4.5%) 14 (3.8%) 17 (3.9%) 0.731
5-min Apgar score below 6 1 (0.8%) 10 (1.7%) 11 (1.5%) 0.699
5-min Apgar score below 7 3 (2.3%) 17 (2.9%) 20 (2.8%) 1.000
Base excess −5.41 ± 3.51 −2.35 ± 3.89 −2.81 ± 3.99 < 0.001
Transfer to neonatal care unit 7 (10.6%) 15 (7.2%) 22 (8.0%) 0.371
Intubation 1 (1.2%) 12 (2.9%) 13 (2.6%) 0.705
VOD vaginal operative delivery, CD cesarean section
Gitas et al. BMC Pregnancy and Childbirth          (2021) 21:356 Page 5 of 8
approaches towards labor. With the aim of achieving de-
livery at the latest 2 h after full cervical dilatation, obste-
tricians may lead women actively through labor, whereas
a longer second stage of labor might favor protraction
and reduce uterine rupture rates. Additionally, a
prolongation of the second stage may cause maternal
exhaustion and favor secondary caesarean section rather
than operative vaginal delivery. These circumstances
may also cause fetal distress and thus contribute to a
higher rate of secondary CD. Unfortunately, we could
not address the success rate of vacuum birth in the two
groups, which could help us to better interpretate our
finding. It is not clear if the physicians performed failed
or less vacuum births if the second stage was already
long. However, according to our experience, a failed
vacuum birth is a rare case. Further research is needed
to enlighten this field.
The safety and effectiveness of operative vaginal deliv-
ery in relation to the outcome and success of TOLAC
were analyzed by Krizman et al. in 1837 patients [28].
Success rates of vaginal operative delivery in TOLAC
were high (forceps 90.4%; vacuum 92.6%), and neonatal
morbidity rates were similar to those for repeat cesarean
delivery. With regard to overall morbidity the authors
conclude that, in order to avoid secondary CD, TOLAC
should be offered to all women with no apparent contrain-
dications for vaginal delivery, and operative vaginal delivery
might be considered more often than considered previ-
ously in these patients. Our study revealed that, after the
establishment of the new guidelines, the number of opera-
tive vaginal deliveries fell from 9.2 to 6.8% and the number
of secondary CD increased. These data confirm the conclu-
sions of the above-mentioned study. Additionally, accord-
ing to our subgroup analysis, operative vaginal delivery has
similar neonatal outcome with the secondary CD. Analytic-
ally, the incidence of postpartum acidosis (pH < 7.1) were
similar in our subgroups (4.5% vs 3.8%) but as expected,
significant higher as by our main groups (1.0% Group I vs.
2.0% Group II). Furthermore, parameters which may be
associated to long-term neonatal outcome, such as 5-min
Apgar scores below 6 or 7 or Apgar scores at 10min, did
not differ statistical significantly between the two groups.
Thus, if we take in considerations the negative maternal
effects of CD [29], operative vaginal delivery should be
preferred, when possible.
In a retrospective investigation performed in 2019,
Miller et al. [30] concluded that an operative interven-
tion might be considered after a two-hour duration of
the second stage of labor without epidural anesthesia, a
three-hour duration with epidural anesthesia, and a one-
hour duration or less in women with a previous vaginal
delivery, for those undergoing TOLAC. These measures
are in accordance with former guidelines. According to
the new guidelines [13, 15], the duration of the second
stage of labor with and without epidural anesthesia
could be at least 4 and 3 h, respectively. Zhang et al. [22]
used an interval-censored regression to analyze labor
curves and suggested that the 95th percentiles of the
second stage of labor in nulliparous women were 3.6
and 2.8 h with and with without epidural anesthesia.
However, only low-risk women were included in the in-
vestigation. Labor curves for high-risk women, such as
those undergoing TOLAC, have not been thoroughly
examined yet. As Zheng et al. suggested, the ideal time
for the second stage of labor would differ by populations
and may be shorter for patients undergoing TOLAC [31].
After application of the new guidelines, we observed a
slight but not statistically significant increase in third-
and fourth-degree perineal lacerations from 0.9 to 1.2%.
Risk factors for third- and fourth-degree perineal lacera-
tions [32], such as the mother’s ethnicity and infants
large for their gestational age, were comparable in both
groups. Furthermore, as the frequency of vaginal opera-
tive deliveries decreased after the establishment of the
new guidelines, a reduction in third- and fourth-degree
perineal lacerations could be expected. In a study com-
prising 19,831 patients, Zipori et al. [25] registered an
increase in third- and fourth-degree perineal lacerations
from 1 to 1.3% after application of the new labor guide-
lines. Third- and fourth-degree perineal lacerations exert
a significant impact on the patients’ quality of life in
terms of higher rates of dyspareunia, wound breakdown
and infection, urinary incontinence, and postpartum
depression secondary to perineal pain [33, 34].
Similar to maternal morbidity, neonatal outcomes did
not differ markedly between Groups I and II in the
present study. The incidence of postpartum acidosis
(pH < 7.1) or severe metabolic acidosis (pH < 7.0) were
similar in both groups. Further essential parameters,
such as the 5-min Apgar scores below 6 or 7 or Apgar
scores at 10 min, did not differ statistical significantly
between the two groups. In our study, the proportion of
5-min Apgar scores below 7 (1.3% in Group I and 2.0%
in Group II) were higher than the medial rate reported
in the literature (less than 1%) [35], which could be
expected due to our high-risk collective. On the other
hand, transfer rates to the neonatal care unit were
significantly higher in Group II than in Group I (11.7%
vs. 4.4%). Unfortunately, we could not find a reasonable
explanation about this difference, which may be associ-
ated with the development of a more safe and accurate
neonatal examination and surveillance in the last years,
an issue which seems to be multifactorial [36]. Further
research is needed in order to enlighten this field.
Sepsis and infection rates were not included in this ana-
lysis because of the small number of cases. Moreover, it
was not possible to analyze the rate of preeclampsia be-
cause of a change in diagnostic criteria during the study
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period. Two recent studies [37, 38] investigating morbidity
and CD prevention rates after application of the new labor
guidelines showed no association between the duration of
the second stage of labor and maternal or neonatal
morbidity. However, some studies revealed increased rates
of chorioamnionitis, sepsis, uterine atony, and third- or
fourth-degree perineal lacerations after a prolonged
second stage of labor [16, 39]. A prolonged second stage
with the aim of reducing CD rates may be associated with
higher maternal and neonatal morbidity rates. Thus, this
strategy is still a controversially discussed issue.
To our knowledge, the current study is the first to
analyze the outcome of patients undergoing TOLAC before
and after the new recommendations of the ACOG/SMFM
[13], especially with regard to the duration of the second
stage of labor. Statistical bias was reduced by the fact that
the present investigation was a multicenter study in a large
population with homogenous groups. However, the limita-
tions of the study are worthy of mention. The retrospective
design called for a careful interpretation of the results. Fac-
tors such as physician’s or midwife’s experience and prefer-
ences were not assessed, and might have accounted for the
results. Furthermore, the retrospective design of the present
study provided a relatively large study population, but was
limited by the documentation performed during the deliv-
eries. Moreover, the size of the study didn’t not allow us to
perform a multivariate regression analysis, which may nega-
tively influence our results and increase the risk of statistical
bias. On the other hand, after the establishment of the new
guidelines, it will be difficult to perform a prospective study
with sufficient numbers of patients.
Conclusions
The present study provides new data about the outcome
of TOLAC after the establishment of the ACOG/SMFM
recommendations concerning the duration of the second
stage of labor. Notably, the investigation revealed that a
prolonged second stage of labor does not necessarily lead
to more vaginal births after TOLAC. We also observed a
reduction in vaginal operative deliveries. Further studies
will have to evaluate the role of the second stage of labor
on CD rates, especially in TOLAC. Several thousands of
patients will be needed to obtain statistically robust data
concerning severe maternal and neonatal complications.
Moreover, prospective studies will be likely to provide
valuable data on the care of women with VBAC. Women
undergoing TOLAC are known to be subject to a higher
risk of obstetric complications; normal labor curves have
not been assessed for them. Based on the existing data, we
conclude that women who have no contraindications for
vaginal delivery should be encouraged to undergo TOLAC
after a careful medical assessment. This should be accom-
panied by careful monitoring at well-equipped centers
with facilities for immediate operative procedures.
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